- Patent Title: 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors
-
Application No.: US15735235Application Date: 2016-06-10
-
Publication No.: US10759793B2Publication Date: 2020-09-01
- Inventor: Cristina Esteve Trias , Joan Taltavull Moll , Jacob Gonzalez Rodriguez , Bernat Vidal Juan
- Applicant: ALMIRALL, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1ec7b3e0
- International Application: PCT/EP2016/063391 WO 20160610
- International Announcement: WO2016/198663 WO 20161215
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D239/24
Abstract:
New 2-(pyrazolopyridin-3-yl)pyrimidine derivatives are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy as inhibitors of Janus Kinases (JAK).
Public/Granted literature
- US20180162856A1 2-(PYRAZOLOPYRIDIN-3-YL)PYRIMIDINE DERIVATIVES AS JAK INHIBITORS Public/Granted day:2018-06-14
Information query
